News Business Sports Entertainment Life Obituaries Opinion
Jobs Homes Cars Classifieds Shopping
Local Bloggers Cheap Tech Eco-Confessions Faceoff Furst Draft Heard on the Street Med City Movie Guy Pulse on Health Political Party

Recent Comments

Search PB Blogs



« Dayton: Minnesota will lead health reform.... #RochMN | Main | Pulse on Health transfers to Twitter... #RochMN »


Mayo Clinic working on glaucoma gene therapy... #RochMN

Genetic Engineering & Biotechnology News is reporting that Mayo Clinic has entered a legal agreement with Great Britain's Oxford BioMedica "to develop a gene therapy for treating chronic glaucoma."

"The partners will carry out preclinical work to test the feasibility of using a therapeutic based on Oxford BioMedica’s LentiVector® gene delivery system…for use in reducing intraocular pressure," the industry news group writes. "The collaboration builds on research by Mayo Clinic scientists that has demonsrated initial proof-of-concept for the gene therapy approach."

When a company gets exclusive rights to license Mayo technology, the income from those intellectual property rights has the potential to bring Mayo millions of dollars — in addition to improving quality-of-life for affected patients.

According to, glaucoma is a group of eye diseases that cause optic nerve damage and loss of vision.

"Glaucoma is the second leading cause of blindness," the clinic reports. "Sometimes called the silent thief of sight, glaucoma can damage your vision so gradually you may not notice any loss of vision until the disease is at an advanced stage."

That's why, the clinic notes, you should get your eyes checked regularly, with ocular pressure tested.

Pulse on Health
By Jeff Hansel, member Association of Health Care Journalists
Health Reporter for the, 18 1st Ave. S.E. in Rochester, Minnesota 55904 
Twitter Hansel's Pulse: @Jeff Hansel


TrackBack URL for this entry:

Listed below are links to weblogs that reference Mayo Clinic working on glaucoma gene therapy... #RochMN:


Feed You can follow this conversation by subscribing to the comment feed for this post.

Post a comment.

Comments are moderated, and will not appear on this weblog until the author has approved them.